Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Characterization of CD44v3-containing isoforms in head and neck cancer.

Reategui EP, de Mayolo AA, Das PM, Astor FC, Singal R, Hamilton KL, Goodwin WJ, Carraway KL, Franzmann EJ.

Cancer Biol Ther. 2006 Sep;5(9):1163-8. Epub 2006 Sep 11.

PMID:
16855392
2.

A novel CD44 v3 isoform is involved in head and neck squamous cell carcinoma progression.

Franzmann EJ, Weed DT, Civantos FJ, Goodwin WJ, Bourguignon LY.

Otolaryngol Head Neck Surg. 2001 Apr;124(4):426-32.

PMID:
11283501
3.

CD44 variant isoforms in head and neck squamous cell carcinoma progression.

Wang SJ, Wong G, de Heer AM, Xia W, Bourguignon LY.

Laryngoscope. 2009 Aug;119(8):1518-30. doi: 10.1002/lary.20506.

4.

Characterization of CD44v6 isoforms in head-and-neck squamous-cell carcinoma.

van Hal NL, van Dongen GA, Stigter-van Walsum M, Snow GB, Brakenhoff RH.

Int J Cancer. 1999 Sep 9;82(6):837-45.

5.

Frequent expression of the high molecular, 673-bp CD44v3,v8-10 variant in colorectal adenomas and carcinomas.

Kopp R, Fichter M, Schalhorn G, Danescu J, Classen S.

Int J Mol Med. 2009 Nov;24(5):677-83.

PMID:
19787202
6.

Evaluation of CD44 variant expression in oral, head and neck squamous cell carcinomas using a triple approach and its clinical significance.

Athanassiou-Papaefthymiou M, Shkeir O, Kim D, Divi V, Matossian M, Owen JH, Czerwinski MJ, Papagerakis P, McHugh J, Bradford CR, Carey TE, Wolf GT, Prince ME, Papagerakis S.

Int J Immunopathol Pharmacol. 2014 Jul-Sep;27(3):337-49.

8.

Dominant negative p63 isoform expression in head and neck squamous cell carcinoma.

Sniezek JC, Matheny KE, Westfall MD, Pietenpol JA.

Laryngoscope. 2004 Dec;114(12):2063-72.

PMID:
15564824
9.

Salivary soluble CD44: a potential molecular marker for head and neck cancer.

Franzmann EJ, Reategui EP, Carraway KL, Hamilton KL, Weed DT, Goodwin WJ.

Cancer Epidemiol Biomarkers Prev. 2005 Mar;14(3):735-9.

10.

A new CD44V3-containing isoform is involved in tumor cell growth and migration during human breast carcinoma progression.

Kalish ED, Iida N, Moffat FL, Bourguignon LY.

Front Biosci. 1999 Jan 1;4:A1-8.

PMID:
9872731
11.

Collagen type XI α1 facilitates head and neck squamous cell cancer growth and invasion.

Sok JC, Lee JA, Dasari S, Joyce S, Contrucci SC, Egloff AM, Trevelline BK, Joshi R, Kumari N, Grandis JR, Thomas SM.

Br J Cancer. 2013 Dec 10;109(12):3049-56. doi: 10.1038/bjc.2013.624. Epub 2013 Nov 14.

12.

Triggering of Toll-like receptor 4 expressed on human head and neck squamous cell carcinoma promotes tumor development and protects the tumor from immune attack.

Szczepanski MJ, Czystowska M, Szajnik M, Harasymczuk M, Boyiadzis M, Kruk-Zagajewska A, Szyfter W, Zeromski J, Whiteside TL.

Cancer Res. 2009 Apr 1;69(7):3105-13. doi: 10.1158/0008-5472.CAN-08-3838. Epub 2009 Mar 24.

13.

Distinct epigenetic profiling in head and neck squamous cell carcinoma stem cells.

Furusawa J, Zhang H, Vural E, Stone A, Fukuda S, Oridate N, Fang H, Ye Y, Suen JY, Fan CY.

Otolaryngol Head Neck Surg. 2011 Jun;144(6):900-9. doi: 10.1177/0194599811398786. Epub 2011 Feb 18.

PMID:
21493336
14.

Tumor suppressive microRNA-218 inhibits cancer cell migration and invasion through targeting laminin-332 in head and neck squamous cell carcinoma.

Kinoshita T, Hanazawa T, Nohata N, Kikkawa N, Enokida H, Yoshino H, Yamasaki T, Hidaka H, Nakagawa M, Okamoto Y, Seki N.

Oncotarget. 2012 Nov;3(11):1386-400.

15.

Role of hyaluronan-mediated CD44 signaling in head and neck squamous cell carcinoma progression and chemoresistance.

Wang SJ, Bourguignon LY.

Am J Pathol. 2011 Mar;178(3):956-63. doi: 10.1016/j.ajpath.2010.11.077. Review.

16.

CD44(high) /ALDH1(high) head and neck squamous cell carcinoma cells exhibit mesenchymal characteristics and GSK3β-dependent cancer stem cell properties.

Seino S, Shigeishi H, Hashikata M, Higashikawa K, Tobiume K, Uetsuki R, Ishida Y, Sasaki K, Naruse T, Rahman MZ, Ono S, Simasue H, Ohta K, Sugiyama M, Takechi M.

J Oral Pathol Med. 2016 Mar;45(3):180-8. doi: 10.1111/jop.12348. Epub 2015 Sep 24.

PMID:
26399460
17.

Activation of Matrix Hyaluronan-Mediated CD44 Signaling, Epigenetic Regulation and Chemoresistance in Head and Neck Cancer Stem Cells.

Bourguignon LYW, Earle C, Shiina M.

Int J Mol Sci. 2017 Aug 24;18(9). pii: E1849. doi: 10.3390/ijms18091849. Review.

19.

Expression of CXCR4 and its down-regulation by IFN-gamma in head and neck squamous cell carcinoma.

Katayama A, Ogino T, Bandoh N, Nonaka S, Harabuchi Y.

Clin Cancer Res. 2005 Apr 15;11(8):2937-46.

20.

Decreased expression of cell adhesion genes in cancer stem-like cells isolated from primary oral squamous cell carcinomas.

Mishra A, Sriram H, Chandarana P, Tanavde V, Kumar RV, Gopinath A, Govindarajan R, Ramaswamy S, Sadasivam S.

Tumour Biol. 2018 May;40(5):1010428318780859. doi: 10.1177/1010428318780859.

PMID:
29888653

Supplemental Content

Support Center